Evaluation of Osteosarcopenia and Biochemical Parameters in People Living with HIV

Introduction: In people living with HIV (PLWH), secondary issues may arise based on the disease itself or the treatments employed. Osteoporosis and sarcopenia are among these health issues, and in this study, our objective was to explore the occurrence of osteosarcopenia in PLWH. This is the first study to simultaneously investigate the co-occurrence of osteoporosis and sarcopenia in PLWH. Materials and Methods: In our study, in which we examined the effect of HIV on osteoporosis and sarcopenia, volunteers between the ages of 18-65 who applied to the infectious diseases outpatient unit were included after obtaining approval from the ethics committee. Results: Among the 50 patients, 44% did not have osteoporosis, while 50% had osteopenia, and 6% had osteoporosis. 10% of the patients had no sarcopenia, 34% had pre-sarcopenia, 40% had sarcopenia, and 16% had severe sarcopenia. Conclusion: The detection of high levels of osteoporosis and sarcopenia in PLWH suggests that HIV disease or HIV-related risk factors have an impact on the musculoskeletal system. Although there was no significant relationship between osteoporosis and sarcopenia in our study, we found that patients with severe sarcopenia were more osteoporotic.